论文部分内容阅读
目的探讨血液理化指标检测结果对脑梗死患者治疗药物选择的影响。方法选取2012年4月至2013年4月在我院接受治疗的144例脑梗死患者,按照血液生物、物理、化学检测的结果可分成血管性血流动力低下型、全血黏度升高型、血小板聚集升高型、纤维蛋白升高型、红细胞压积升高型、混合型。并且通过检测发现,临床使用8种注射药物更适用于何种脑梗死亚型。结果维脑路通适用于血管性血流动力低下型;刺五加、路路通、血栓通、血塞通适用于血黏度升高型;丹奥适用于血小板聚集升高型;降纤酶适用于纤维蛋白升高型;复方丹参适用于全血黏度升高型、血红细胞积压升高型。结论按照该分型法治疗脑梗死对药物的选择更加规范、确切,使治疗更有针对性,减少了用药费用,节省了有限的药物资源。
Objective To investigate the effect of blood physical and chemical indexes on the choice of therapeutic drugs in patients with cerebral infarction. Methods A total of 144 patients with cerebral infarction who were treated in our hospital from April 2012 to April 2013 were divided into three groups according to the results of blood biophysical and chemical tests: Elevated platelet aggregation, elevated fibrin, elevated hematocrit, mixed type. And through the test found that the clinical use of 8 kinds of injectable drugs is more suitable for what type of cerebral infarction. Results Venoruton for vascular hypoflower; Acanthopanax senticosus, Lulu Tong, Xueshuantong, Xuesaitong applicable to elevated blood viscosity; Danao for platelet aggregation type; defibrase Suitable for elevated fibrin; Fufang Danshen for the whole blood viscosity, red blood cell backlog type. Conclusion The treatment of cerebral infarction according to the typing method is more standardized and exact for the treatment of cerebral infarction, making the treatment more specific, reducing the cost of medication and saving limited drug resources.